Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 80 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Jiang F.

Korea, Republic of

USD 80 /hr

Medical and academic writer with 10+ years of experience in Clinical Research (Oncology, Pharmacology, Genetics)

Profile Summary

I have over 10 years of experience in clinical pharmacology research at several prestigious institutions, including Seoul National University and the Korean FDA (now known as the Ministry of Food and Drug Safety). All my previous positions have been related to clinical studies, requiring extensive review and writing skills, as well as strong communication and problem-solving abilities. I hold a GCP training certificate and am well-versed in all aspects and procedures of clinical trials, including potential challenges that may arise. In my most recent role as a Translational Research Team Manager, I worked at a Korean company developing cancer immunotherapies. I led a multidisciplinary team and collaborated closely with oncologists, laboratory researchers, and professionals in process development, quality, and business departments to compile scientific content for new cancer drug development. My key responsibilities included: - Managing multiple translational research projects for IND applications. - Gathering knowledge from relevant sources (publications, clinical trials, regulatory guidance, and conferences) to support first-in-human clinical studies. - Providing drug-specific and protocol-oriented training to oncologists participating in first-in-human studies. Currently, I work online as a freelance medical consultant for an international, multidisciplinary team based in Korea. One of our key projects focuses on developing breast cancer treatment-specific educational programs for doctors. I also have extensive experience engaging with key opinion leaders in oncology. (Jan 2022)

Subject Matter Expertise

• ★ Clinical Trials
• ★ Precision Medicine
• ★ Immunotherapy
• ☆ Pharmacogenomics
• ☆ Hematology-Oncology
• ☆ Psychopharmacology

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Medical Writing, Technical Writing

Research Market Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Data Visualization, Big Data Analytics

Product Development Product Evaluation

Work Experience

Senior Medical Advisor

Jin Medical Science Service

November 2019 - Present

Regional Medical Director

Regeneron Pharmaceuticals

November 2023 - December 2024

Chief Researcher

Prestige BioPharma

January 2022 - November 2023

Chief Scientific Officer

SPMED Co., Ltd.

March 2021 - October 2021

Translational Research Team Manager

Bionoxx Inc.

September 2017 - January 2021

Assosiate Professor

Sun Yat-Sen University

January 2017 - November 2017

Postodoctoral Fellow

Seoul National University

June 2014 - July 2015

Senior Research

Korea Ministry of Food and Drug Safety

April 2013 - May 2014

Education

Doctor of Philosophy

Inje University

March 2007 - January 2013

Masters of Science

Inje University

March 2005 - January 2007

Masters of Science

Central South University - China

September 2003 - September 2006

Medical Degree (MD)

Central South University - China

September 1998 - July 2003

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2021). Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study) . Journal of clinical medicine.

(2020). A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for <i>EGFR</i> Mutations in Plasma from Non-Small Cell Lung Cancer Patients . Cancers.

(2020). A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer . British journal of cancer.

(2020). Evaluation of Two <i>EGFR</i> Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer . Cancers.

(2020). Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase . Cancers.

(2019). Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes . Cancer research and treatment.

(2018). Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus . Drug design, development and therapy.

(2018). Genetic analysis of sick sinus syndrome in a family harboring compound CACNA1C and TTN mutations . Molecular medicine reports.

(2018). Prognostic significance of hypoxia inducible factor-1α expression in patients with clear cell renal cell carcinoma . Molecular medicine reports.

(2017). The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition . Pharmacogenomics.

(2014). The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes . Psychopharmacology.

(2013). Population pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenz . Journal of clinical pharmacology.

(2013). A pilot study on intravesical administration of curcumin for cystitis glandularis . Evidence-based complementary and alternative medicine : eCAM.

(2013). Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals . Pharmacogenetics and genomics.

(2013). Reply to: Letter to the editor "Impact of the CYP2C19*17 polymorphism on the pharmacokinetics and pharmacodynamics of proton pump inhibitors" . Journal of clinical pharmacology.

(2013). Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index . British journal of clinical pharmacology.

Rapid and Simultaneous Determination of Efavirenz, 8-Hydroxyefavirenz, and 8,14-Dihydroxyefavirenz Using LC–MS–MS in Human Plasma and Application to Pharmacokinetics in Healthy Volunteers @article{2011, doi = {10.1007/s10337-010-1882-5}, url = {https://doi.org/10.1007%2Fs10337-010-1882-5}, year = 2011, month = {jan}, publisher = {Springer Science and Business Media {LLC}}, volume = {73}, number = {3-4}, pages = {263--271}, author = {Kwon-Bok Kim and Hyunmi Kim and Fen Jiang and Chang-Woo Yeo and Soo Kyung Bae and Zeruesenay Desta and Jae-Gook Shin and Kwang-Hyeon Liu}, title = {Rapid and Simultaneous Determination of Efavirenz, 8-Hydroxyefavirenz, and 8,14-Dihydroxyefavirenz Using {LC}{\textendash}{MS}{\textendash}{MS} in Human Plasma and Application to Pharmacokinetics in Healthy Volunteers}} . Chromatographia.

(2009). Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers . The Annals of pharmacotherapy.

(2009). Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers . Xenobiotica; the fate of foreign compounds in biological systems.

(2008). Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation . European journal of clinical pharmacology.

(2006). Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males . Clinica chimica acta; international journal of clinical chemistry.